MDS experts, Dr Alan List and Dr David Sallman, provide an overview of
hypomethylating agents for the treatment of
myelodysplastic syndromes (
MDS). These medications work by turning on genes to kill the cancer cells. Examples discussed are
azacitidine and
decitabine. The doctors describe how these drugs are given, how they work, and potential side effects.
-
Share with family and friends:
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about MDS which will help other patients, caregivers and families.